-Jacob George Researcher Activity Profile

Research Author Detailed Information 

Jacob George Publication Rate By Year

Jacob George has published 2 paper(s) in 2006, 12 paper(s) in 2007, 8 paper(s) in 2008, for a total of 22 research publications in total.

Jacob J George Author Information

LAST NAME: george

FIRST NAME: jacob

INITIALS: J

AFFILIATION:

Papers

Jacob George's Publication Record

1. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Year Published: 2006
Gastroenterology Department, University of Turin, Italy. ebugianesi@yahoo.it
2. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Year Published: 2007
Storr Liver Unit, Westmead Millennium Institute and Department of Gastroenterology and Hepatology, University of Sydney at Westmead Hospital, Westmead, New South Wales, Australia.
3. Modelling the hepatitis C virus epidemic in Australia. Year Published: 2007
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia. krazali@nchecr.unsw.edu.au
4. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury. Year Published: 2007
Department of Physical Medicine and Rehabilitation, Christian Medical College, Vellore, Tamil Nadu, India. jacobg@cmcvellore.ac.in
5. Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure. Year Published: 2007
Ninewells Hospital, Department of Clinical Pharmacology, Level 7, Dundee DD1 9SY, Scotland, UK. j.george@dundee.ac.uk
6. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury. Year Published: 2007
Department of Physical Medicine and Rehabilitation, Christian Medical College, Vellore, Tamil Nadu, India. jacobg@cmcvellore.ac.in
7. Liver disease in adolescents: A cohort study of high-risk individuals. Year Published: 2007
Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Sydney, Australia.
8. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. Year Published: 2007
Storr Liver Unit, Westmead Millennium Institute, University of Sydney and Westmead Hospital, NSW, Australia; Digestive Disease Research Centre, Shartati Hospital, Medical Science/University of Tehran, Iran.
9. Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure. Year Published: 2007
Ninewells Hospital, Department of Clinical Pharmacology, Level 7, Dundee DD1 9SY, Scotland, UK. j.george@dundee.ac.uk
10. Drug modification of angiogenesis in a rat cornea model. Year Published: 2008
Department of Ophthalmology, Assaf Harofeh Medical Center, Zrifin, Israel; the.
11. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Year Published: 2007
Storr Liver Unit, Westmead Millennium Institute and Department of Gastroenterology and Hepatology, University of Sydney at Westmead Hospital, Westmead, New South Wales, Australia.
12. Liver disease in adolescents: A cohort study of high-risk individuals. Year Published: 2007
Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Sydney, Australia.
13. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Year Published: 2006
Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Sackler School of Medicine, Tel Aviv 64239, Israel.
14. Nonalcoholic Fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. Year Published: 2008
c.liddle@usyd.edu.au.
15. Drug modification of angiogenesis in a rat cornea model. Year Published: 2008
Department of Ophthalmology, Assaf Harofeh Medical Center, 6 Weizman Street, Zrifin, Israel.
16. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. Year Published: 2007
Storr Liver Unit, Westmead Millennium Institute, University of Sydney and Westmead Hospital, NSW, Australia.
17. Drug modification of angiogenesis in a rat cornea model. Year Published: 2008
Department of Ophthalmology, Assaf Harofeh Medical Center, 6 Weizman Street, Zrifin, Israel.
18. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4(+)CD25(+) T cells. Year Published: 2008
The Department of Cardiology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
19. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Year Published: 2008
The Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
20. Modelling the hepatitis C virus epidemic in Australia. Year Published: 2007
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia. krazali@nchecr.unsw.edu.au
21. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Year Published: 2008
The Department of Cardiology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
22. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Year Published: 2008
The Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.